Target Price | €27.12 |
Price | €19.54 |
Potential | 38.75% |
Number of Estimates | 17 |
17 Analysts have issued a price target Bayer 2025 . The average Bayer target price is €27.12. This is 38.75% higher than the current stock price. The highest price target is €37.00 89.32% , the lowest is €22.00 12.57% . | |
A rating was issued by 19 analysts: 4 Analysts recommend Bayer to buy, 15 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bayer stock has an average upside potential 2025 of 38.75% . Most analysts recommend the Bayer stock at Hold. |
16 Analysts have issued a sales forecast Bayer 2024 . The average Bayer sales estimate is €46.4b . This is 0.73% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €47.5b 1.73% , the lowest is €45.8b 2.12% .
This results in the following potential growth metrics:
2023 | €47.6b | 6.11% |
---|---|---|
2024 | €46.4b | 2.61% |
2025 | €46.8b | 0.83% |
2026 | €47.7b | 1.97% |
2027 | €48.2b | 0.97% |
2028 | €49.3b | 2.28% |
16 Analysts have issued an Bayer EBITDA forecast 2024. The average Bayer EBITDA estimate is €10.2b . This is 8.41% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €10.9b 2.06% , the lowest is €9.9b 10.50% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | €12.3b | 1.26% |
---|---|---|
2024 | €10.2b | 17.54% |
2025 | €9.9b | 2.34% |
2026 | €10.4b | 4.18% |
2027 | €10.2b | 1.45% |
2028 | €11.0b | 7.70% |
2023 | 25.91% | 7.86% |
---|---|---|
2024 | 21.93% | 15.36% |
2025 | 21.25% | 3.10% |
2026 | 21.71% | 2.16% |
2027 | 21.18% | 2.44% |
2028 | 22.30% | 5.29% |
10 Bayer Analysts have issued a net profit forecast 2024. The average Bayer net profit estimate is €835m . This is 194.43% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €3.6b 512.22% , the lowest is €-1.9b 120.00% .
This results in the following potential growth metrics and future Net Margins:
2023 | €-2.9b | 170.85% |
---|---|---|
2024 | €835m | 128.42% |
2025 | €2.7b | 217.88% |
2026 | €3.1b | 15.08% |
2027 | €3.4b | 11.72% |
2028 | €3.8b | 12.71% |
2023 | -6.17% | 175.47% |
---|---|---|
2024 | 1.80% | 129.19% |
2025 | 5.67% | 215.00% |
2026 | 6.40% | 12.87% |
2027 | 7.08% | 10.63% |
2028 | 7.81% | 10.31% |
10 Analysts have issued a Bayer forecast for earnings per share. The average Bayer <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is €0.85 . This is 194.44% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is €3.71 512.22% , the lowest is €-1.98 120.00% .
This results in the following potential growth metrics and future valuations:
2023 | €-2.99 | 170.85% |
---|---|---|
2024 | €0.85 | 128.43% |
2025 | €2.70 | 217.65% |
2026 | €3.11 | 15.19% |
2027 | €3.47 | 11.58% |
2028 | €3.91 | 12.68% |
Current | -21.82 | 96.58% |
---|---|---|
2024 | 23.00 | 205.41% |
2025 | 7.23 | 68.57% |
2026 | 6.29 | 13.00% |
2027 | 5.63 | 10.49% |
2028 | 4.99 | 11.37% |
Based on analysts' sales estimates for 2024, the Bayer stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 1.20 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 0.41 .
This results in the following potential growth metrics and future valuations:
Current | 1.20 | 29.82% |
---|---|---|
2024 | 1.20 | 0.37% |
2025 | 1.19 | 0.82% |
2026 | 1.17 | 1.93% |
2027 | 1.16 | 0.96% |
2028 | 1.13 | 2.23% |
Current | 0.41 | 51.81% |
---|---|---|
2024 | 0.41 | 0.73% |
2025 | 0.41 | 0.82% |
2026 | 0.40 | 1.92% |
2027 | 0.40 | 0.97% |
2028 | 0.39 | 2.23% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.